CORC

在结果中检索

CORC

浏览/检索结果: 共48条，第1-10条 帮助

限定条件                
已选(0)清除 条数/页：   排序方式：
A MULTICENTRE, RANDOMISED, DOUBLE-BLIND, PARALLEL ACTIVE-CONTROLLED CLINICAL TRIAL COMPARING PHARMACOKINETICS, PHARMACODYNAMICS, SAFETY AND EXPLORATORY EFFICACY BETWEEN HLX01 AND EUROPE-SOURCED RITUXIMAB AS A NEW INDICATION IN CHINESE MODERATE TO 会议论文
ANNALS OF THE RHEUMATIC DISEASES, 2019-06-01
作者:  Zeng, Xiaofeng;  Wang, Yongfu;  Jiang, Zhenyu;  Zhang, Zhuoli;  He, Lan
收藏  |  浏览/下载：45/0  |  提交时间：2020/01/03
A MULTICENTRE, RANDOMISED, DOUBLE-BLIND, PARALLEL ACTIVE-CONTROLLED CLINICAL TRIAL COMPARING PHARMACOKINETICS, PHARMACODYNAMICS, SAFETY AND EXPLORATORY EFFICACY BETWEEN HLX01 AND EUROPE-SOURCED RITUXIMAB AS A NEW INDICATION IN CHINESE MODERATE TO 期刊论文
2019, 卷号: 78, 页码: 1140-1140
作者:  Zeng, Xiaofeng;  Wang, Yongfu;  Jiang, Zhenyu;  Zhang, Zhuoli;  He, Lan
收藏  |  浏览/下载：41/0  |  提交时间：2020/01/03
Role of Radiation Therapy in Younger and Older Adults with Primary Mediastinal Large B Cell Lymphoma in Rituximab Era: A U.S. Population-Based Analysis 期刊论文
2019
作者:  Jiang Shiyu;  Zhen Hongnan;  Jiang Hongxin
收藏  |  浏览/下载：2/0  |  提交时间：2020/01/03
Primary breast diffuse large B-cell lymphoma in the rituximab era: therapeutic strategies and patterns of failure (vol 109, pg 3943, 2018) 期刊论文
2019, 卷号: 110, 期号: 4, 页码: 1503-1503
作者:  Hu, Shaoxuan;  Song, Yuqin;  Sun, Xiuhua;  Su, Liping;  Zhang, Wei
收藏  |  浏览/下载：66/0  |  提交时间：2020/01/03
Primary extra-nodal diffuse large B-cell lymphoma: A prognostic analysis of 141 patients 期刊论文
2018, 卷号: 16, 期号: 2, 页码: 1602-1614
作者:  Shen Haorui;  Wei Zhang;  Zhou Daobin;  Zhang Yan;  Han Xiao
收藏  |  浏览/下载：4/0  |  提交时间：2020/01/03
Primary breast diffuse large B-cell lymphoma in the rituximab era: Therapeutic strategies and patterns of failure 期刊论文
2018, 卷号: 109, 期号: 12, 页码: 3943-3952
作者:  Hu, Shaoxuan;  Song, Yuqin;  Sun, Xiuhua;  Su, Liping;  Zhang, Wei
收藏  |  浏览/下载：18/0  |  提交时间：2020/01/03
Effectiveness of rituximab-containing treatment regimens in idiopathic multicentric Castleman disease 期刊论文
2018, 卷号: 97, 期号: 9, 页码: 1641-1647
作者:  Dong, Yujun;  Zhang, Lu;  Nong, Lin;  Wang, Lihong;  Liang, Zeyin
收藏  |  浏览/下载：8/0  |  提交时间：2020/01/03
Ibrutinib versus rituximab in relapsed or refractory chronic lymphocytic leukemia or small lymphocytic lymphoma: a randomized, open-label phase 3 study 期刊论文
2018, 卷号: 7, 期号: 4, 页码: 1043-1055
作者:  Huang, Xiaojun;  Qiu, Lugui;  Jin, Jie;  Zhou, Daobin;  Chen, Xiequn
收藏  |  浏览/下载：9/0  |  提交时间：2020/01/03
T-cell lymphoma with abundant CD20 expression showing a good response to rituximab with gemcitabine, oxiplatin, and L-asparaginase (R-pGEMOX) A case report 期刊论文
2018, 卷号: 97, 期号: 12, 页码: e0199
作者:  Shao, Yajuan;  Bai, Chunmei;  Sun, Jian;  Gao, Xin
收藏  |  浏览/下载：33/0  |  提交时间：2020/01/03
First china-manufactured proposed rituximab biosimilar met primary efficacy and safety endpoints in CD20-positive diffuse large B-cell lymphoma (generics) 期刊论文
2018, 卷号: 29
作者:  Shi, Y.;  Zhang, Q.;  Han, X.;  Song, Y.;  Qin, Y.
收藏  |  浏览/下载：11/0  |  提交时间：2020/01/03

©版权所有 ©2017 CSpace - Powered by CSpace